William Blair on Medline Inc (MDLN) Post Conference: 'Management reiterated the most recent FDA warning letter is isolated'
Tweet Send to a Friend
William Blair analyst Brandon Vazquez reiterated an Outperform rating and {REMOVEPT} price target on Medline Inc (NASDAQ: MDLN).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
